Article
Effects of the investigational drug sodium phenylbutyrate-TUDCA (AMX0035) on the…
medRxiv · 2022 · Fels, J. A.; Dash, J.; Leslie, K.; Manfredi, G.; Kawamata, H.
Key facts
| Title | Effects of the investigational drug sodium phenylbutyrate-TUDCA (AMX0035) on the transcriptional and metabolic landscape of sporadic ALS fibroblasts |
|---|---|
| First author | Fels, J. A.; Dash, J.; Leslie, K.; Manfredi, G.; Kawamata, H. |
| Journal | medRxiv |
| Published | May 2, 2022 |
| DOI | 10.1101/2022.05.02.490306 |
| Product codes mentioned | PFT |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1